NAPANEE, ON, Dec. 31, 2020 /CNW/ - VIVO Cannabis
Inc. (TSX: VIVO), (OTCQX: VVCIF) ("VIVO" or the
"Company") today announced that in conjunction with its
annual employee compensation program, it has granted, effective
today, an aggregate of 6,900,000 million stock options (each,
an "Option") to certain officers, employees and consultants
of the Company in accordance with the Company's stock option plan.
Each Option is exercisable into one common share in the capital of
the Company (each, a "Share") at a price of $0.13 per Share, being the closing price of the
Shares on the TSX on December 30,
2020, for a period of five years from the date of the grant.
This option grant makes up part of the compensation and retention
incentives anticipated by our stock option plan. All full time
employees of the Company will receive Options under this
normal-course business grant. The Options will vest in equal
quarterly instalments over 36 months.
About VIVO Cannabis™
VIVO Cannabis™ is recognized for trusted, premium cannabis
products and services. It holds production and sales licences from
Health Canada and operates world-class indoor and seasonal airhouse
cultivation facilities. VIVO has a collection of premium brands,
each targeting different customer segments, including Canna Farms™,
Beacon Medical™, Fireside™, Fireside-X™, Lumina™ and Canadian
Bud Collection™. Harvest Medicine,
VIVO's patient-centric, scalable network of medical cannabis
clinics, has serviced over 150,000 patient visits. VIVO is pursuing
several partnership and product development opportunities and is
focusing its international efforts on Germany and Australia. For more information visit:
vivocannabis.com
SOURCE VIVO Cannabis Inc.
